277 related articles for article (PubMed ID: 31539297)
1. Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study.
Chévez-Barrios P; Eagle RC; Krailo M; Piao J; Albert DM; Gao Y; Vemuganti G; Ali MJ; Khetan V; Honavar SG; O'Brien J; Leahey AM; Matthay K; Meadows A; Chintagumpala M
J Clin Oncol; 2019 Nov; 37(31):2883-2891. PubMed ID: 31539297
[TBL] [Abstract][Full Text] [Related]
2. Delayed Enucleation With Neoadjuvant Chemotherapy in Advanced Intraocular Unilateral Retinoblastoma: AHOPCA II, a Prospective, Multi-Institutional Protocol in Central America.
Luna-Fineman S; Chantada G; Alejos A; Amador G; Barnoya M; Castellanos ME; Fu L; Fuentes-Alabi S; Girón V; Goenz MA; Maldonado C; Méndez G; Morales RA; Ortiz R; Sanchez G; Wilson M; Rodríguez-Galindo C
J Clin Oncol; 2019 Nov; 37(31):2875-2882. PubMed ID: 31536438
[TBL] [Abstract][Full Text] [Related]
3. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma.
Kaliki S; Shields CL; Shah SU; Eagle RC; Shields JA; Leahey A
Arch Ophthalmol; 2011 Nov; 129(11):1422-7. PubMed ID: 22084213
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination.
Uusitalo MS; Van Quill KR; Scott IU; Matthay KK; Murray TG; O'Brien JM
Arch Ophthalmol; 2001 Jan; 119(1):41-8. PubMed ID: 11146725
[TBL] [Abstract][Full Text] [Related]
5. Clinical features predictive of high-risk retinoblastoma in 403 Asian Indian patients: a case-control study.
Kaliki S; Srinivasan V; Gupta A; Mishra DK; Naik MN
Ophthalmology; 2015 Jun; 122(6):1165-72. PubMed ID: 25841975
[TBL] [Abstract][Full Text] [Related]
6. Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.
Brennan RC; Qaddoumi I; Billups CA; Free TL; Haik BG; Rodriguez-Galindo C; Wilson MW
Br J Ophthalmol; 2015 Oct; 99(10):1366-71. PubMed ID: 25873648
[TBL] [Abstract][Full Text] [Related]
7. Results of a prospective study for the treatment of unilateral retinoblastoma.
Chantada GL; Fandiño AC; Guitter MR; Raslawski EC; Dominguez JL; Manzitti J; de Dávila MT; Zubizarreta P; Scopinaro M
Pediatr Blood Cancer; 2010 Jul; 55(1):60-6. PubMed ID: 20486172
[TBL] [Abstract][Full Text] [Related]
8. Outcome of children with retinoblastoma and isolated choroidal invasion.
Bosaleh A; Sampor C; Solernou V; Fandiño A; Domínguez J; de Dávila MT; Chantada GL
Arch Ophthalmol; 2012 Jun; 130(6):724-9. PubMed ID: 22801832
[TBL] [Abstract][Full Text] [Related]
9. Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.
Berry JL; Kogachi K; Aziz HA; McGovern K; Zolfaghari E; Murphree AL; Jubran R; Kim JW
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 28221729
[TBL] [Abstract][Full Text] [Related]
10. Results of a prospective study for the treatment of retinoblastoma.
Chantada G; Fandiño A; Dávila MT; Manzitti J; Raslawski E; Casak S; Schvartzman E
Cancer; 2004 Feb; 100(4):834-42. PubMed ID: 14770442
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Nonmetastatic Unilateral Retinoblastoma in Children.
Pérez V; Sampor C; Rey G; Parareda-Salles A; Kopp K; Dabezies AP; Dufort G; Zelter M; López JP; Urbieta M; Alcalde-Ruiz E; Catala-Mora J; Suñol M; Ossandon D; Fandiño AC; Croxatto JO; de Dávila MTG; Reaman G; Ravindranath Y; Chantada GL
JAMA Ophthalmol; 2018 Jul; 136(7):747-752. PubMed ID: 29799944
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre.
Künkele A; Wilm J; Holdt M; Lohmann D; Bornfeld N; Eggert A; Temming P; Schulte JH
Br J Ophthalmol; 2015 Jul; 99(7):949-53. PubMed ID: 25583279
[TBL] [Abstract][Full Text] [Related]
13. High-risk retinoblastoma based on international classification of retinoblastoma: analysis of 519 enucleated eyes.
Kaliki S; Shields CL; Rojanaporn D; Al-Dahmash S; McLaughlin JP; Shields JA; Eagle RC
Ophthalmology; 2013 May; 120(5):997-1003. PubMed ID: 23399379
[TBL] [Abstract][Full Text] [Related]
14. Defining High-risk Retinoblastoma: A Multicenter Global Survey.
Kaliki S; Shields CL; Cassoux N; Munier FL; Chantada G; Grossniklaus HE; Yoshikawa H; Fabian ID; Berry JL; McKenzie JD; Kimani K; Reddy MA; Parulekar M; Tanabe M; Furuta M; Grigorovski N; Chevez-Barrios P; Scanlan P; Eagle RC; Rashid R; Coronado RD; Sultana S; Staffieri S; Frenkel S; Suzuki S; Ushakova TL; Ji X
JAMA Ophthalmol; 2022 Jan; 140(1):30-36. PubMed ID: 34762098
[TBL] [Abstract][Full Text] [Related]
15. Anterior Chamber Invasion in Retinoblastoma: Not an Indication for Adjuvant Chemotherapy.
Sreelakshmi KV; Chandra A; Krishnakumar S; Natarajan V; Khetan V
Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4654-4661. PubMed ID: 28903151
[TBL] [Abstract][Full Text] [Related]
16. The Potential Benefit of Three vs. Six Cycles of Carboplatin, Etoposide, and Vincristine in Postenucleation High-Risk Patients with IRSS Stage I Retinoblastoma.
Ye H; Du Y; Chen R; Luo X; Mao Y; Ai S; Ma W; Ding Y; Li Q; Yang H
Curr Eye Res; 2016 Nov; 41(11):1507-1512. PubMed ID: 27158739
[TBL] [Abstract][Full Text] [Related]
17. Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleation.
Aerts I; Sastre-Garau X; Savignoni A; Lumbroso-Le Rouic L; Thebaud-Leculée E; Frappaz D; Coze C; Thomas C; Gauthier-Villars M; Lévy-Gabriel C; Brisse HJ; Desjardins L; Doz F
J Clin Oncol; 2013 Apr; 31(11):1458-63. PubMed ID: 23460706
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy with vincristine, doxorubicin, and cyclophosphamide in the treatment of postenucleation high risk retinoblastoma.
Mustafa MM; Jamshed A; Khafaga Y; Mourad WA; Al-Mesfer S; Kofide A; El-Husseiny G; Gray A
J Pediatr Hematol Oncol; 1999; 21(5):364-9. PubMed ID: 10524448
[TBL] [Abstract][Full Text] [Related]
19. Clinical Predictors at Diagnosis of Low-Risk Histopathology in Unilateral Advanced Retinoblastoma.
Kletke SN; Feng ZX; Hazrati LN; Gallie BL; Soliman SE
Ophthalmology; 2019 Sep; 126(9):1306-1314. PubMed ID: 30986443
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.
Chantada GL; Dunkel IJ; Antoneli CB; de Dávila MT; Arias V; Beaverson K; Fandiño AC; Chojniak M; Abramson DH
Pediatr Blood Cancer; 2007 Sep; 49(3):256-60. PubMed ID: 17029248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]